|
Re: Votes In
|
1
|
Resverlogix Corp.
|
Jun 19, 2023 10:47AM
|
|
Re: Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients
|
1
|
Resverlogix Corp.
|
Jun 14, 2023 07:25AM
|
|
Re: "Do we actually have a Breakthrough Therapy Designation?"
|
4
|
Resverlogix Corp.
|
Jun 13, 2023 03:37PM
|
|
Re: Breakthrough Therapy Designation
|
3
|
Resverlogix Corp.
|
Jun 13, 2023 12:45PM
|
|
Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients
|
4
|
Resverlogix Corp.
|
Jun 12, 2023 07:23AM
|
|
Re: Voting reminder
|
5
|
Resverlogix Corp.
|
Jun 11, 2023 10:09AM
|
|
Re: Voting reminder
|
3
|
Resverlogix Corp.
|
Jun 09, 2023 10:16AM
|
|
Re: Are big things about tp happen regarding xB3?
|
1
|
BIOASIS TECHNOLOGIES INC
|
Jun 08, 2023 06:36AM
|
|
Re: almost a 32% drop on the rvxcf shot position over the last two reports.
|
2
|
Resverlogix Corp.
|
Jun 05, 2023 04:11PM
|
|
Re: AGM
|
1
|
Resverlogix Corp.
|
Jun 05, 2023 12:02PM
|
|
Re: Maybe timing is everything…
|
1
|
Resverlogix Corp.
|
Jun 05, 2023 08:38AM
|
|
Re: Maybe timing is everything…
|
1
|
Resverlogix Corp.
|
Jun 05, 2023 08:09AM
|
|
Re: Maybe timing is everything…
|
3
|
Resverlogix Corp.
|
Jun 04, 2023 09:47AM
|
|
Additional Exempt Distribution- 2023-05-11
|
3
|
Zenith Epigenetics
|
Jun 02, 2023 08:38AM
|
|
Re: Zenith Epigenetics Reports Advancement of ZEN-3694 in NUT Carcinoma
|
3
|
Zenith Epigenetics
|
Jun 02, 2023 07:38AM
|
|
Re: RVX Long Covid Trial
|
1
|
Resverlogix Corp.
|
May 30, 2023 09:19AM
|
|
Re: RVX Long Covid Trial
|
|
Resverlogix Corp.
|
May 29, 2023 02:05PM
|
|
Re: RVX Long Covid Trial
|
|
Resverlogix Corp.
|
May 29, 2023 06:16AM
|
|
Additional Reports of Exempt Distribution - 2023-05-15
|
3
|
Resverlogix Corp.
|
May 29, 2023 06:08AM
|
|
Re: RVX Long Covid Trial
|
|
Resverlogix Corp.
|
May 28, 2023 04:51PM
|
